@daxvibezofficial: Who sang this 🎶🧐🚀🚀

Dax Vibez
Dax Vibez
Open In TikTok:
Region: UG
Saturday 26 September 2026 15:21:23 GMT
64680
10749
149
76

Music

Download

Comments

mozelolyte
☆O.z.e.L.y.t.e°♤🇺🇬 :
Muhoozi tolifuga Uganda 🇺🇬
2026-09-26 15:25:25
62
phantie.m.q
💫Phantie💙🌹M.Q :
😂🔥🔥💙 i don't know but the song is nice
2026-09-26 15:26:35
55
favoured1.8m1
favoured1.8m💙 🦋 :
bategeke match Zayra vs Dax Zayra vs Ivo official Zayra vs Ykee Benda Zayra vs Mikey seems Zayra vs Sonny 😁😁mwe abasobola one on one 💙🦋
2026-09-26 15:50:17
40
sabr3649
sabr :
Bambi u love her so much 🥺thank u
2026-09-26 16:42:10
1
fromyourfriend4
from your friend :
oli arya coco ono arya Ani?????🙏
2026-09-26 16:05:18
27
.mint446
Mint :
Bamuyita Alpha Zabu[Pray]
2026-09-26 20:00:12
1
nessimpanproduction
Nessim :
Laila Mwana gwe [Fire]
2026-09-26 17:46:03
7
alphazaabu
Alpha Zaabu ⭐️ :
Thanx so much papa
2026-09-26 17:49:58
1
alpha.zaabu.creat
Alpha zaabu creations :
Twalamu nze🥰
2026-09-26 17:24:18
1
tonn.ywirtz67
tonnywirtz67 :
that my guy
2026-09-26 15:23:58
0
lover.bway
lover bway :
is she zary
2026-09-26 15:24:46
7
martha41ug
Martha❣️Ug :
on the mabere???
2026-09-26 15:50:03
6
mercy.munaaba
Marcie 💓💥💋 :
wabula day va bby waffe😂
2026-09-26 15:52:33
1
mutima.furniture
mutima furniture world :
furniture wange mwamuzila
2026-09-26 15:56:04
7
lovelegend06
Muni.fashions :
Kale zayra singa akuwako
2026-09-26 16:59:54
5
nevin940
Nevin123 :
Our only Ugandan Tyla💙
2026-09-26 16:13:50
14
slimbae234
self Queenie❤️‍🩹 :
Mummy blue 💙
2026-09-26 15:30:17
7
barbie.queen.of.d
B²❤️💋 :
😂😂
2026-09-26 16:23:03
1
alphazaabu
Alpha Zaabu ⭐️ :
Clear
2026-09-26 17:51:52
2
baseme03
fahima24 :
2026-09-26 15:27:39
2
zziwatravis162
Zziwa Travis :
yaa man oli star 🌟 💪💪💪🥰🥰
2026-09-26 15:37:41
4
razzlejey2026
RAZZLE JEY MUSIC :
kankubirw panch
2026-09-26 15:25:32
4
mutima22
Woman💗 :
my favorite people on this App[Heartwarming]
2026-09-26 15:47:58
4
cute.momo989
cute momo :
alpha zaabu🥰🥰
2026-09-26 17:03:07
3
mr.rhine8
Mr Rhine✨ :
Sika zilwa kanooo
2026-09-26 15:57:12
2
To see more videos from user @daxvibezofficial, please go to the Tikwm homepage.

Other Videos

Headline Hype vs. Clinical Reality  When headlines use words like “terrifying” around GLP-1s, it’s normal to feel concerned. Looking past clickbait to understand real-world clinical math helps you make confident, empowered health decisions. 1. Relative vs. Absolute Risk News outlets love relative risk because big multipliers drive clicks. Relative Risk: If a rare condition goes from 1 in 10,000 to 2 in 10,000, headlines scream
Headline Hype vs. Clinical Reality When headlines use words like “terrifying” around GLP-1s, it’s normal to feel concerned. Looking past clickbait to understand real-world clinical math helps you make confident, empowered health decisions. 1. Relative vs. Absolute Risk News outlets love relative risk because big multipliers drive clicks. Relative Risk: If a rare condition goes from 1 in 10,000 to 2 in 10,000, headlines scream "100% RISK INCREASE!" Absolute Risk: Your real-world chance only changed by 0.01% (from 0.01% to 0.02%). 2. The Vision Loss Risk (NAION) The Math: Multi-year registry data shows the cumulative absolute risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) for GLP-1 users remains low, at 3 to 4 cases per 10,000 people (<0.04%). Clinical Consensus: The AAO and NANOS joint consensus confirms that while a modest relative association exists (~2-fold), direct causality is unproven. ****Always monitor for visual changes and consult your provider. 3. The Unsung Benefit: Cancer Reduction Scary headlines ignore major positive clinical data (JAMA Oncology, JAMA Network Open). GLP-1s lower obesity-associated cancer risks across both relative and absolute metrics: Overall Cancer: An absolute drop of 2.8 fewer cases/1,000 people/year (drops from 16.4 to 13.6 per 1,000 person-years — a 17% relative reduction). Endometrial Cancer: An absolute drop of ~0.4 fewer cases/1,000 person-years (a 25% relative reduction). Ovarian Cancer: An absolute drop of ~0.2 fewer cases/1,000 person-years (a 47% relative reduction). Colorectal Cancer: An absolute drop of ~0.5–1 fewer cases/1,000 person-years (up to a 28% relative reduction). By improving metabolic health, lowering fasting insulin, and calming systemic inflammation, GLP-1s address root drivers of cellular damage. Educational Only. Not Medical Advice. It is still important to monitor for any visual changes, research any medication or supplement you take, and discuss any concerns directly with your provider. Silence Medical PLLC | Evidence-based metabolic care focused on muscle preservation. 📲 Telemedicine in AZ, CO, & OR | www.silencemed.com References Hathaway JT, Shah MP, Hathaway DB, et al. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. JAMA Ophthalmol. 2024;142(8):731–739. doi:10.1001/jamaophthalmol.2024.2296 Grauslund J, et al. Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy. Acta Ophthalmol. Published online 2024. PMID: 39696569. DeParis S, Oke I, Gaier E, et al. Glucagon-like peptide-1 receptor agonists and the risk of non-arteritic anterior ischemic optic neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology. Ophthalmology. Published online August 2026. Biousse V. Consensus Statement Shows a Possible Small Association Between GLP-1 RA Drugs and NAION. American Academy of Ophthalmology (AAO) Editor's Choice. Published August 27, 2026. Dai H, Li Y, Lee Y, et al. GLP-1 receptor agonists and cancer risk in adults with obesity. JAMA Oncol. 2025;11(10):e252681. doi:10.1001/jamaoncol.2025.2681 Wang L, Xu R, Kaelber DC, Berger NA. GLP-1 Receptor Agonists and Risk of Obesity-Associated Cancers in Patients With Type 2 Diabetes. JAMA Netw Open. 2024;7(7):e2421305. doi:10.1001/jamanetworkopen.2024.21305 #GLP1 #WeightLossJourney #Telehealth #SilenceMedical #Semaglutide

About